Generic Drugmakers May Face Supply Shortages From China If Coronavirus Drags On

Generic Drugmakers May Face Supply Shortages From China If Coronavirus Drags On

ndtv.com

Generic drugmakers say they currently have enough API supplies from China.

Shortages and potential price increases of generic drugs from India loom if the coronavirus outbreak disrupts suppliers of pharmaceutical ingredients in China past April, according to industry experts.

An important supplier of generic drugs to the world, Indian companies procure almost 70 per cent of the active pharmaceutical ingredients (APIs) for their medicines from China.

India's generic drugmakers say they currently have enough API supplies from China to cover their operations for up to about three months.

"We are comfortably placed with eight to 10 weeks of key inventory in place," said Debabrata Chakravorty, head of global sourcing and supply chain for Lupin Ltd, adding that the company does have some local suppliers for ingredients.

Optimism that the worst of the outbreak centered in China's Hubei province and its capital Wuhan would be over by April took a major hit late on Wednesday. Chinese health officials, using a broader method of confirming coronavirus cases, said they shot up by nearly 15,000 in Hubei with total deaths in China nearing 1,400.

Disclaimer: This is an automatically aggregated article/story by a computer program and has not been created or edited by Newsdig.in.
Advt
Advt
Advt
sitemap Disclaimer
Newsdig.in 2019